Photo by Ben Scicluna.
Merck plans to seek FDA approval for its quadrivalent Gardasil HPV vaccine in men later this year:
Merck has been testing the vaccine in an international study...focused on anal and penile cancer and genital warts...said Kelley Dougherty, a Merck spokeswoman....No data from Merck's study are available yet.
